NCT03426722View on ClinicalTrials.gov

L-carnitine vs Placebo for the Treatment of Muscle Cramps After Imatinib in Gastrointestinal Stromal Tumors

PHASE3CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

December 24, 2019

Study Completion Date

December 24, 2019

Conditions
Gastrointestinal Stromal Tumors (GISTs)
Interventions
DRUG

L-carnitine

"* L-carnitine VS Placebo is randomized (1:1)~* L-carnitine 500mg TID(PO),~* First evaluation will be performed at 8 weeks and then unblinding will be done. If symptoms continue after treatment, dose escalation in L-carnitine group by 1000mg TID (PO). If symptoms continue after treatment in Placebo group, L-carnitine 500mg TID(PO) will be given."

DRUG

Placebo

Placebo 500mg TID(PO)

Trial Locations (1)

05505

Asan Medical Center, University of Ulsan College of Medicine, Seoul

Sponsors
All Listed Sponsors
collaborator

Hanmi Pharmaceutical Company Limited

INDUSTRY

lead

Asan Medical Center

OTHER